ABCB1 and leukemia: Thus daunorubicin- and stress-induced acute induction of ABCB1 can overcome pharmacologic inhibition of ABCB1, leading to leukemia cell survival, and this can, at least in part, be mitigated by concomitant treatment of cells with inhibitors of stress signaling.